======= TFCP2L1 ======= == Gene Information == * **Official Symbol**: TFCP2L1 * **Official Name**: transcription factor CP2 like 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=29842|29842]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NZI6|Q9NZI6]] * **Interactions**: [[https://thebiogrid.org/search.php?search=TFCP2L1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TFCP2L1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/609785|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Transcription factor that facilitates establishment and maintenance of pluripotency in embryonic stem cells (ESCs) (PubMed:25215486, PubMed:26906118). With KLF2, acts as the major effector of self-renewal that mediates induction of pluripotency downstream of LIF/STAT3 and Wnt/beta-catenin signaling (By similarity). Required for normal duct development in the salivary gland and kidney (By similarity). Coordinates the development of the kidney collecting ducts intercalated (IC) and principal (PC) cells, which regulate acid-base and salt-water homeostasis, respectively (By similarity). Regulates the expression of IC genes including subunits B1 and D2 of the V-ATPase complex, OXGR1, CA12, SLC4A1, AQP6 and IC-specific transcription factor FOXI1 (By similarity). Regulates also the expression of JAG1 and subsequent notch signaling in the collecting duct (By similarity). JAG1 initiates notch signaling in PCs but inhibits notch signaling in ICs (By similarity). Acts as a transcriptional suppressor that may suppress UBP1-mediated transcriptional activation (By similarity). Modulates the placental expression of CYP11A1 (PubMed:10644752). {ECO:0000250|UniProtKB:Q3UNW5, ECO:0000269|PubMed:10644752, ECO:0000269|PubMed:25215486, ECO:0000269|PubMed:26906118}. |CP2| |cytoplasm organization| |epithelial cell maturation| |determination of adult lifespan| |salivary gland development| |multicellular organism aging| |exocrine system development| |steroid biosynthetic process| |fibrillar center| |anatomical structure maturation| |cell maturation| |female pregnancy| |epithelial cell development| |multi-multicellular organism process| |developmental maturation| |transcription corepressor activity| |positive regulation of growth| |steroid metabolic process| |aging| |RNA polymerase II regulatory region sequence-specific DNA binding| |gland development| |sequence-specific DNA binding| |lipid biosynthetic process| |regulation of growth| |DNA-binding transcription factor activity| |epithelial cell differentiation| |cell morphogenesis| |cellular component morphogenesis| |negative regulation of transcription by RNA polymerase II| |multi-organism reproductive process| |epithelium development| |negative regulation of transcription, DNA-templated| |lipid metabolic process| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |mitochondrion| |organic cyclic compound biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |reproductive process| |reproduction| |negative regulation of nucleobase-containing compound metabolic process| |negative regulation of macromolecule biosynthetic process| |negative regulation of cellular biosynthetic process| |negative regulation of biosynthetic process| |DNA-binding transcription factor activity, RNA polymerase II-specific| |cell development| |negative regulation of gene expression| |tissue development| |membrane| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 10288 * **Expression level (log2 read counts)**: 1.5 {{:chemogenomics:nalm6 dist.png?nolink |}}